Sort By:
Featured

Pneumonia Vaccine

Rochester Clinical Research is currently enrolling generally healthy individuals between the ages of 18-49 years old for a vaccine research study. The study will assess the safety and tolerability of two different dosage levels of study vaccine that may protect against a greater number of strains of pneumococcal disease. The study will last approximately 6 months with two visits to our office (within the first 30 days) and 3 telephone calls. Compensation may be available for time and travel up to $225, for those who qualify.

View Trial Details
Ages 18 - 49
Compensation* $225
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Featured

RSV Vaccine

This study will evaluate the safety and effectiveness of an RSV vaccine in women between the ages of 18-45 to increase antibodies to RSV infection. The study will last approximately 6 months with 4 visits to our office and 1 telephone call. Compensation is available for time and travel up to $600, for those who qualify.

View Trial Details
Ages 18 - 45
Gender For female patients only
Compensation* $600
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Featured

E. Coli Vaccine

RCR is currently enrolling healthy 60-85 year olds to evaluate a vaccine that could potentially prevent E. Coli that can cause sepsis.

View Trial Details
Ages 60 - 85
Compensation* $300
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.

View Trial Details
Ages 0 - 1
Study Topics Pediatric, Vaccine